These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1099187)

  • 1. Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity.
    Taeusch HW
    J Pediatr; 1975 Oct; 87(4):617-23. PubMed ID: 1099187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid therapy in the fetus and newborn--Introduction.
    Dammann O; Matthews SG
    Semin Neonatol; 2001 Aug; 6(4):283-4. PubMed ID: 11972429
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature].
    Gandibleux-Bergiers MF
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids and the respiratory distress syndrome.
    Johnson JW; Beck JC; Haberkern CM
    Obstet Gynecol Annu; 1984; 13():99-129. PubMed ID: 6371622
    [No Abstract]   [Full Text] [Related]  

  • 5. Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome.
    Shields JR; Resnik R
    Obstet Gynecol Surv; 1979 May; 34(5):343-63. PubMed ID: 379720
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of multiple courses of corticosteroid treatment.
    Lenke R
    Am J Obstet Gynecol; 2000 Feb; 182(2):478-9. PubMed ID: 10694356
    [No Abstract]   [Full Text] [Related]  

  • 7. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids.
    Jobe AH; Newnham J; Willet K; Sly P; Ikegami M
    Pediatrics; 1998 Nov; 102(5):1116-25. PubMed ID: 9794943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?
    Morrison JL; Botting KJ; Soo PS; McGillick EV; Hiscock J; Zhang S; McMillen IC; Orgeig S
    J Pregnancy; 2012; 2012():839656. PubMed ID: 23227338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal prevention of the respiratory syndrome. I. Current status of knowledge].
    Meriggi E; Parenti MR
    Minerva Ginecol; 1980 Mar; 32(3):175-86. PubMed ID: 6103524
    [No Abstract]   [Full Text] [Related]  

  • 10. Antenatal prevention of the neonatal respiratory distress syndrome: benefits and potential risks for the mother and the infant.
    Papageorgiou A; Stern L
    J Perinat Med; 1986; 14(2):75-86. PubMed ID: 3525809
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory distress syndrome: the preventive use of glucocorticoids.
    Haller CC; King CR
    J Kans Med Soc; 1981 Mar; 82(3):98-106. PubMed ID: 6895085
    [No Abstract]   [Full Text] [Related]  

  • 12. [The current status of inducing fetal lung maturity for prevention of neonatal respiratory distress syndrome].
    Ragosch V; Weitzel H
    Gynakologe; 1995 Jun; 28(3):203-10. PubMed ID: 7657182
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of prenatal glucocorticoid therapy to prevent respiratory distress syndrome. A supporting view.
    Ballard RA; Ballard PL
    Am J Dis Child; 1976 Sep; 130(9):982-7. PubMed ID: 961661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Corticosteroid for fetal lung maturation: indication and treatment protocols].
    Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S105-13. PubMed ID: 12454632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection.
    Schmidt PL; Sims ME; Strassner HT; Paul RH; Mueller E; McCart D
    Am J Obstet Gynecol; 1984 Jan; 148(2):178-86. PubMed ID: 6691394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antenatal steroids on fetal lung maturation between the 34th and 36th week of pregnancy.
    Balci O; Ozdemir S; Mahmoud AS; Acar A; Colakoglu MC
    Gynecol Obstet Invest; 2010; 70(2):95-9. PubMed ID: 20234136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective.
    O'Shea TM; Doyle LW
    Semin Neonatol; 2001 Aug; 6(4):293-307. PubMed ID: 11972431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid effects in the fetal lung.
    Ballard PL; Benson BJ; Brehier A
    Am Rev Respir Dis; 1977 Jun; 115(6 Pt 2):29-36. PubMed ID: 577381
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
    Kinalski M; Sledziewski A; Kretowski A
    Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal betamethasone: reassuring long-term data.
    Prescrire Int; 2008 Apr; 17(94):73. PubMed ID: 18536142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.